Ozempic Face and Loose Skin Surge Drives DMV Patients to The Naderi Center's Advanced Non-Surgical & Surgical Treatments

January 12, 2026 8:00 AM

As rapid weight-loss medications such as Ozempic and Wegovy become increasingly popular, patients across the Washington, DC metropolitan area are noticing unexpected side effects: sudden facial volume loss, loose skin, and accelerated signs of aging. The Naderi Center for Plastic Surgery & Dermatology, with offices in Chevy Chase, Maryland-near Washington, DC-and Reston, Virginia, is seeing a dramatic rise in patients seeking expert guidance and...

Read more

Aytu BioPharma Details Agenda for Investor Day Scheduled for January 20, 2026 in New York City

January 12, 2026 8:00 AM

DENVER, CO / ACCESS Newswire / January 12, 2026 / Aytu BioPharma, Inc. (the "Company" or "Aytu") (Nasdaq:AYTU), a pharmaceutical company focused on advancing innovative medicines for complex central nervous system diseases to improve the quality of life for patients, today provided additional details for its upcoming Investor Day, scheduled for Tuesday, January 20, 2026, at 11:00 a.m. Eastern time in New York City. The Investor Day will be both...

Read more

GridAI: The Grid Is the New Battleground for AI Economics

January 12, 2026 8:00 AM

For years, investors were trained to believe the bottleneck in artificial intelligence would be chips. Then it was talent. Then it was data. Each time, the market adjusted, capital flowed, and new winners emerged. What has changed quietly, but decisively, is where that constraint now lives.Electricity.Not electricity in the abstract sense of power generation, but in the operational sense of when energy is available, where it can flow, and how...

Read more

TRTInjections.com Launches to Simplify TRT Education for Clinics and Patients

January 12, 2026 7:35 AM

TRTInjections.com announced today the public launch of its new educational platform built to help TRT clinics and TRT users quickly access clear, practical injection guidance in one place. Designed for busy providers and real world patients alike, the site delivers a streamlined experience that makes it easier to learn proper injection site selection, understand rotation basics, and follow consistent technique standards without wading through...

Read more

OBI Pharma and TegMine Therapeutics Sign Exclusive Global License Agreement for Glycan-Targeting ADC

January 12, 2026 7:00 AM

OBI Pharma (4174.TWO) announced that it has entered into a commercial license agreement with TegMine Therapeutics, Inc. (TegMine), a San Francisco-based biopharma focused on developing antibodies targeting cancer-associated glycans and glycoproteins, for a glycan-targeting ADC.Under the terms of the agreement, OBI is eligible to receive an upfront payment as well as development and commercial milestones. Following product launch, OBI will also...

Read more

Black Book Research Releases 2026 State of South Korean Acute Care EMR Digital Adoption Report

January 12, 2026 7:00 AM

Black Book Research today announced the release of its 2026 State of South Korean Acute Care EMR Digital Adoption report, a stakeholder-validated strategic fit assessment of seven core acute-care EMR/HIS/EHR platforms and six enabling ecosystem platforms across four provider segments and 18 qualitative strategic fit dimensions over the 2026-2030 planning horizon.South Korea's acute-care market, among the most digitally mature globally, has...

Read more

Moderna Provides Business and Pipeline Updates at 44th Annual J.P. Morgan Healthcare Conference

January 12, 2026 7:00 AM

Moderna, Inc. (NASDAQ:MRNA) today announced business updates and progress across its pipeline of mRNA medicines. Moderna enters 2026 with a focus on growing sales, launching new infectious disease products and delivering pivotal readouts across oncology, rare disease and infectious disease portfolios."In 2025, we strengthened our commercial execution, successfully launched our third product, and continued to advance our mRNA pipeline. At the...

Read more

Amphastar Pharmaceuticals Announces Exclusive License Agreement with Nanjing Hanxin Pharmaceutical Technology Co., Ltd. for Fully Synthetic Corticotropin Compound

January 12, 2026 6:00 AM

Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) today announced that it has entered into an exclusive license agreement (the "Agreement") with Nanjing Hanxin Pharmaceutical Technology Co., Ltd. ("Hanxin") for the development, and commercialization of a fully synthetic and highly purified human adrenocorticotropic hormone (ACTH) analogs (also termed corticotropin), now designated AMP-110, in the United States and Canada. AMP-110 is designed to...

Read more

Monthly Update December - A Year of Breakthroughs, Expansion and International Consolidation

January 12, 2026 5:20 AM

iZafe Group (STO:IZAFE-B) - As we summarize December and at the same time leave 2025 behind, it is clear that the year has been one of the most transformative in iZafe Group's history. We have taken clear steps from growth toward scalable expansion, with increased demand, a stronger partner network, and establishment in new markets. We have continued to build on our success in Sweden while simultaneously laying the foundation for something even...

Read more

CelLBxHealth PLC Announces Board Changes

January 12, 2026 2:10 AM

CelLBxHealth plc (AIM:CLBX), a leader in circulating tumour cell (CTC) intelligence, with tests and services supporting research, drug development and clinical oncology, is pleased to announce that further to the announcement of 15 December 2025, that the following have been appointed to the board with immediate effect:Peter Collins as Chief Executive OfficerKlaas de Boer as Non-Executive DirectorKim Oreskovic as Non-Executive DirectorBenjamin...

Read more

Pre-JPM Investor Pulse Signals 2026 Capital Rotation Toward "AI That Ships," Admin Cost Takeout, and Differentiated Metabolic Assets With Special-Situations Capital Back in Scope

January 11, 2026 10:15 AM

Black Book Market Research today published a preliminary, directional preview of a Pre-JPM Investor Pulse, designed to quantify what venture capital, private equity, and investment banking participants are most actively seeking to fund, advise, acquire, or syndicate during JPM Week 2026 (Jan. 12-15). The preview summarizes modeled/indicative findings based on early outreach patterns and a targeted respondent mix of 88 industry...

Read more

Olympian Gabby Thomas Draws Crowd at Wellness Event with BetterWay(TM) Blood Testing at H-E-B SoCo

January 10, 2026 6:15 PM

BetterWay™ blood testing by Babson Diagnostics, a science-first healthcare technology company transforming diagnostic blood testing, hosted Olympic gold medalist and public health advocate Gabby Thomas at H-E-B's iconic South Congress store on Saturday, January 10 for Live Well Your Way Day. The free-admission, community-focused event attended by hundreds launched BetterWay's Track Like Gabby™ powered by BetterWay™ campaign, an initiative to...

Read more

Best Weight Loss Pills for 2026: FDA Approves First Oral GLP-1 and What It Means for Patients

January 10, 2026 4:15 PM

The phrase best weight loss pills for 2026 reflects common consumer search behavior and is used here to evaluate treatment options, access pathways, and decision criteria. It does not imply endorsement, ranking, or medical recommendation. This analysis reviews publicly available data to help readers independently assess weight loss medication options. Disclaimer: This article is for informational purposes only and does not provide medical...

Read more

Avant Brands Adopts Shareholder Rights Plan

January 9, 2026 4:30 PM

Avant Brands Inc. (TSX:AVNT)(OTCQX:AVTBF)(FRA:1BU0) ("Avant" or the "Company"), a leading producer of innovative and award-winning cannabis products, announces that its board of directors (the "Board") has approved the adoption of a shareholder rights plan (the "Shareholder Rights Plan"), pursuant to a shareholder rights plan agreement entered into with Computershare Investor Services Inc., as rights agent, dated and effective January 9,...

Read more

Desert Oasis Healthcare Recognized as a Fortune Best (Large) Workplace in Healthcare for Six Consecutive Years

January 9, 2026 10:00 AM

Desert Oasis Healthcare (DOHC) has been recognized as one of Fortune's Best (Large) Workplaces in Healthcare for six consecutive years, from 2020 through 2025, underscoring DOHC's sustained commitment to a people-first culture and excellence in healthcare delivery.The annual Fortune Best Workplaces in Healthcare list is based on confidential employee feedback, evaluating trust, respect, fairness, pride, and camaraderie in the workplace. DOHC's...

Read more

Aptevo Therapeutics Secures $60 Million Equity Line of Credit to Support Multispecific Portfolio Advancement, Increase Strategic Optionality

January 9, 2026 8:05 AM

Aptevo Therapeutics Inc. (NASDAQ:APVO), a clinical-stage biotechnology Company focused on developing novel immune-oncology therapeutics based on its proprietary ADAPTIR® and ADAPTIR-FLEX® platform technologies, today announced that the Company has entered into a $60 million equity line of credit (ELOC) agreement with Yorkville Advisors Global, LP, strengthening the Company's financial flexibility as it continues to advance its clinical and...

Read more

Curiteva Announces First Clinical Use of Inspire Standalone ALIF System

January 9, 2026 8:00 AM

Curiteva, Inc., a leading technology and manufacturing company, proudly announces the first cases using its Inspire Standalone ALIF System. This milestone completes the company's anterior launch strategy and establishes the Inspire portfolio as a comprehensive, 360-degree solution for surgeons addressing spinal pathologies. This press release follows the recent publication of a peer-reviewed study in the Journal of Biomaterials, highlighting...

Read more

LA Breast and Body Announces New Advances in Aesthetic Flat Closure Techniques

January 9, 2026 5:00 AM

Dr. Wai-Yee Li of LA Breast and Body introduces groundbreaking insights on aesthetic flat closure, offering patients a personalized, compassionate approach to chest wall reconstruction.Dr. Wai-Yee Li, a board-certified plastic surgeon and founder of LA Breast and Body, is pioneering a personalized approach to breast surgery, with a particular focus on breast reconstruction and aesthetic flat closure procedures. These advancements challenge...

Read more

Umbrella Labs Introduces Research Use Only 5 AMINO 1MQ Liquid Program To Support High Rigor NNMT, NAD+ Salvage, And Methyl Donor Bench Science

January 9, 2026 2:45 AM

Umbrella Labs today announced the availability of 5 AMINO 1MQ as a research use only small molecule chemical probe supported by a documentation first workflow built for laboratories that need traceable materials, consistent handling guidance, and assay aware characterization for enzyme inhibition studies. Product access for 5 AMINO 1MQ liquid in the Umbrella Labs catalog is available here:...

Read more

Nevada Donor Network Awarded Southern Florida Designated Service Area by CMS Following Competitive National Bid Process

January 8, 2026 4:30 PM

Nevada Donor Network (NDN) announced today that it has been awarded the Southern Florida Designated Service Area (DSA) by the Centers for Medicare & Medicaid Services (CMS) following an extensive and highly competitive bid process initiated after the decertification of Life Alliance Organ Recovery Agency (LAORA) in September 2025.The CMS decision reflects confidence in NDN's proven ability to stabilize, rebuild, and lead high-performing organ...

Read more